Japan’s DIC Corporation has acquired PCAS Canada from PCAS, a legacy subsidiary of Seqens, for an enterprise value of €82 million, and has renamed it Innovation DIC Chimitroniques. This follows agreement by both boards and the workers’ council.

PCAS Canada has a facility near Montreal producing photoresists for semiconductor photolithography, an area in which DIC expects substantial growth. DIC will combine these with its own syntheis technologies and will continue to invest in the site.